To explore the concentration of squamous cell carcinoma antigen (SCCA), cytokeratin fragment antigen 21-1 (CYFRA21-1) in patients with laryngeal squamous cell carcinoma (LSCC) and its correlation with tumorigenesis and progression.
A total of 78 patients with LSCC admitted to our hospital from February 2010 to January 2016 were enrolled as the research group (RG), and another 41 healthy volunteers from the same period were selected as the control group (CG). The serum concentrations of SCCA and CYFRA21-1 in patients with LSCC were detected by ELISA, whose diagnostic value in LSCC were further analyzed by ROC curve. The prognosis and survival curves of patients with LSCC were observed according to the median value of serum SCCA and CYFRA21-1 concentrations.
The concentration of CYFRA21-1 and SCCA in the RG was significantly higher than that in the CG (p < 0.050). The SCCA and CYFRA21-1 identified a significant difference in smoking, lymphatic metastasis, TNM staging, and differentiation degree (p < 0.050). The survival rate of the SCCA low-concentration group was significantly better than that of the high-concentration group, p < 0.050. The survival rate of the CYFRA21-1 low-concentration group was markedly better than that of the high-concentration group, p < 0.050.
SCCA and CYFRA21-1 are highly concentrated in LSCC patients, which have good diagnostic efficacy for LSCC. In addition, they play some certain role in the occurrence and development of LSCC, and are expected to be markers for early diagnosis and prognosis of this disease.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41:673–95.
Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282–7.
Argiris A, Karamouzis MV, Raben D, et al. Head and neck cancer. Lancet. 2008;371:1695–709.
Marchiano E, Patel DM, Patel TD, et al. Subglottic squamous cell carcinoma: a population-based study of 889 cases. Otolaryngol Head Neck Surg. 2016;154:315–21.
Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51: 15–36. CA Cancer J Clin. 2001;2001(51):144.
Torrente MC, Rodrigo JP, Haigentz M Jr, et al. Human papillomavirus infections in laryngeal cancer. Head Neck. 2011;33:581–6.
De Foer B, Hermans R, Van der Goten A, et al. Imaging features in 35 cases of submucosal laryngeal mass lesions. Eur Radio. 1996;6:913–9.
Saleh EM, Mancuso AA, Stringer SP. CT of submucosal and occult laryngeal masses. J Comput Assist Tomogr. 1992;16:87–93.
Task Force, Ahn SH, Hong HJ, et al. Guidelines for the surgical management of laryngeal cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol. 2017;10:1.
Li X, Zhou J, Huang K, et al. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study. PLoS ONE. 2015;10:e0122361.
Kulpa J, Wójcik E, Reinfuss M, et al. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem. 2002;48:1931–7.
Al-Shagahin H, Alkotyfan K, Müller HH, et al. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma. Anticancer Res. 2009;29:3421–5.
Silverberg E, Lubera JA. Cancer statistics, 1988. CA Cancer J Clin. 1988;38:5–22.
Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116:1–13.
Shah JP, Tollefsen HR. Epidermoid carcinoma of the supraglottic larynx: role of neck dissection in initial surgical treatment. Am J Surg. 1974;128:494–8.
Hawkins NV. The treatment of glottic carcinoma: an analysis of 800 cases. Laryngoscope. 1975;85:1485–93.
Wolf GT, Fisher SG, Hong WK, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–90.
Zhao Q, Duan R, Yuan J, et al. A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array. Int J Nanomed. 2014;9:1097.
Kato H. Expression and function of squamous cell carcinoma antigen. Anticancer Res. 1996;16:2149–53.
Qu T, Zhang J, Xu N, et al. Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer. Oncol Lett. 2019;17:4293–8.
Yuan C, Yang K, Tang H, et al. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma. Onco Targets Ther. 2016;9:3381.
Conflict of interest
The authors declare that they have no conflict of interest.
The study was approved by Ethical Committee of Affiliated Hospital of Weifang Medical University and conducted in accordance with the ethical standards.
All the subjects signed the informed consent.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ji, M., Zhang, L.J. Expression levels of SCCA and CYFRA 21-1 in serum of patients with laryngeal squamous cell carcinoma and their correlation with tumorigenesis and progression. Clin Transl Oncol (2020). https://doi.org/10.1007/s12094-020-02417-4
- Laryngeal squamous cell carcinoma
- Squamous cell carcinoma antigen
- Diagnostic value